These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 33380151)

  • 1. Sulfonylurea derivatives and risk of hypoglycaemia in type 2 diabetic patients.
    Svěcený J; Jirušková J; Hrach K; Radovnická L; Laštůvka J
    Vnitr Lek; 2020; 66(6):35-42. PubMed ID: 33380151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Higher incidence of severe hypoglycaemia leading to hospital admission in Type 2 diabetic patients treated with long-acting versus short-acting sulphonylureas.
    Stahl M; Berger W
    Diabet Med; 1999 Jul; 16(7):586-90. PubMed ID: 10445835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of and risk factors for severe hypoglycaemia in treated type 2 diabetes mellitus patients in the UK--a nested case-control analysis.
    Bruderer SG; Bodmer M; Jick SS; Bader G; Schlienger RG; Meier CR
    Diabetes Obes Metab; 2014 Sep; 16(9):801-11. PubMed ID: 24612200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoglycaemia requiring medical assistance in patients with diabetes: a prospective multicentre survey in tertiary hospitals.
    Liatis S; Mylona M; Kalopita S; Papazafiropoulou A; Karamagkiolis S; Melidonis A; Xilomenos A; Ioannidis I; Kaltsas G; Lanaras L; Papas S; Basagiannis C; Kokkinos A
    Diabetes Metab; 2015 Apr; 41(2):126-31. PubMed ID: 25468446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Access to emergency room for hypoglycaemia in people with diabetes.
    Salutini E; Bianchi C; Santini M; Dardano A; Daniele G; Penno G; Miccoli R; Del Prato S
    Diabetes Metab Res Rev; 2015 Oct; 31(7):745-51. PubMed ID: 26044573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of hypoglycaemia in users of sulphonylureas compared with metformin in relation to renal function and sulphonylurea metabolite group: population based cohort study.
    van Dalem J; Brouwers MC; Stehouwer CD; Krings A; Leufkens HG; Driessen JH; de Vries F; Burden AM
    BMJ; 2016 Jul; 354():i3625. PubMed ID: 27413017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe hypoglycaemia during treatment with sulphonylureas in patients with type 2 diabetes in the Capital Region of Denmark.
    Pilemann-Lyberg S; Thorsteinsson B; Snorgaard O; Zander M; Vestergaard H; Røder ME
    Diabetes Res Clin Pract; 2015 Nov; 110(2):202-7. PubMed ID: 26515912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoglycemia, treatment discontinuation, and costs in patients with type 2 diabetes mellitus on oral antidiabetic drugs.
    Bron M; Marynchenko M; Yang H; Yu AP; Wu EQ
    Postgrad Med; 2012 Jan; 124(1):124-32. PubMed ID: 22314122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe hypoglycemia is associated with antidiabetic oral treatment compared with insulin analogs in nursing home patients with type 2 diabetes and dementia: results from the DIMORA study.
    Abbatecola AM; Bo M; Barbagallo M; Incalzi RA; Pilotto A; Bellelli G; Maggi S; Paolisso G;
    J Am Med Dir Assoc; 2015 Apr; 16(4):349.e7-12. PubMed ID: 25669671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe hypoglycaemia the "tip of the iceberg": an underestimated risk in both type 1 and type 2 diabetic patients.
    Halimi S
    Diabetes Metab; 2015 Apr; 41(2):105-6. PubMed ID: 25824635
    [No Abstract]   [Full Text] [Related]  

  • 11. Fluoroquinolones and the risk of severe hypoglycaemia among sulphonylurea users: Population-based cohort study.
    Dimakos J; Cui Y; Platt RW; Renoux C; Filion KB; Douros A
    Diabetes Obes Metab; 2024 Aug; 26(8):3088-3098. PubMed ID: 38698651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative tolerability of sulphonylureas in diabetes mellitus.
    Harrower AD
    Drug Saf; 2000 Apr; 22(4):313-20. PubMed ID: 10789825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Addition of dipeptidyl peptidase-4 inhibitors to sulphonylureas and risk of hypoglycaemia: systematic review and meta-analysis.
    Salvo F; Moore N; Arnaud M; Robinson P; Raschi E; De Ponti F; Bégaud B; Pariente A
    BMJ; 2016 May; 353():i2231. PubMed ID: 27142267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral antidiabetic agents: current role in type 2 diabetes mellitus.
    Krentz AJ; Bailey CJ
    Drugs; 2005; 65(3):385-411. PubMed ID: 15669880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoglycaemia seriousness and weight gain as determinants of cardiovascular disease outcomes among sulfonylurea users.
    Nunes AP; Iglay K; Radican L; Engel SS; Yang J; Doherty MC; Dore DD
    Diabetes Obes Metab; 2017 Oct; 19(10):1425-1435. PubMed ID: 28497592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Safety Comparison of Metformin vs Sulfonylurea Initiation in Patients With Type 2 Diabetes and Chronic Kidney Disease: A Retrospective Cohort Study.
    Whitlock RH; Hougen I; Komenda P; Rigatto C; Clemens KK; Tangri N
    Mayo Clin Proc; 2020 Jan; 95(1):90-100. PubMed ID: 31902433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative Effectiveness of Insulin versus Combination Sulfonylurea and Insulin: a Cohort Study of Veterans with Type 2 Diabetes.
    Min JY; Griffin MR; Hung AM; Grijalva CG; Greevy RA; Liu X; Elasy T; Roumie CL
    J Gen Intern Med; 2016 Jun; 31(6):638-46. PubMed ID: 26921160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of once-daily insulin detemir on oral antidiabetic drug (OAD) use in patients with type 2 diabetes.
    Vora J; Caputo S; Damci T; Orozco-Beltran D; Pan C; Svendsen AL; Sølje KS; Khunti K;
    J Clin Pharm Ther; 2014 Apr; 39(2):136-43. PubMed ID: 24329524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review of prandial glucose regulation with repaglinide: a solution to the problem of hypoglycaemia in the treatment of Type 2 diabetes?
    Nattrass M; Lauritzen T
    Int J Obes Relat Metab Disord; 2000 Sep; 24 Suppl 3():S21-31. PubMed ID: 11063281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HYPOGLYCEMIA INDUCED BY ANTIDIABETIC SULFONYLUREAS.
    Confederat L; Constantin S; Lupaşcu F; Pânzariu A; Hăncianu M; Profire L
    Rev Med Chir Soc Med Nat Iasi; 2015; 119(2):579-84. PubMed ID: 26204670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.